Explore the excitement of Incredibox Sprunki PHASE 3 and 4 recreated in real life with live instruments. Each rhythm, beat, and melody is carefully transformed from digital sound into a dynamic ...

When two babies are born to the same mother in less than 12 months, they are often called "Irish twins." Lindsey Campbell can top that. She's the mom of "Irish triplets," meaning that she gave birth ...

This is read by an automated voice. Please report any issues or inconsistencies here. Tyler Reddick is the first NASCAR Cup Series driver to win the first three races of a season. Michael Jordan, the ...

Tyler Reddick isn't exactly the Michael Jordan of NASCAR. Not yet anyway. Still, Reddick seems to be at the start of something special as the driver of a team co-owned by the NBA legend who led the ...

NASCAR driver Tyler Reddick celebrates with 23XI co-owner Michael Jordan after winning his third straight race to start the season, while wife Alexa holds son Beau. (James Gilbert / Getty Images) ...

The Duggars can count a new addition into the family. Indeed, John-David Duggar and Abbie Duggar welcomed their third baby together, a little girl, the couple announced. “John and Abbie - party of 5!” ...

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...

- Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

COATESVILLE — A father is in custody, accused of stabbing his 3-month-old baby and then throwing the infant into the snow. On Wednesday, February 11, at approximately 11:30 a.m. Coatesville Police ...

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...

Trials aim to optimize frontline therapies for CLL, multiple myeloma, SLL, and pediatric acute leukemia/MDS, focusing on high-risk, treatment-naïve patients. Investigations include BTK inhibitors, CAR ...